News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
786,549 Results
Type
Article (55658)
Company Profile (489)
Press Release (730382)
Multimedia
Podcasts (158)
Webinars (26)
Section
Business (217698)
Career Advice (2886)
Deals (37444)
Drug Delivery (157)
Drug Development (87363)
Employer Resources (185)
FDA (17512)
Job Trends (16031)
News (370176)
Policy (35801)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2959)
Academic (1)
Accelerated approval (46)
Adcomms (34)
Allergies (178)
Alliances (53295)
ALS (213)
Alzheimer's disease (1883)
Antibody-drug conjugate (ADC) (466)
Approvals (17786)
Artificial intelligence (689)
Autoimmune disease (263)
Automation (53)
Bankruptcy (392)
Best Places to Work (12282)
BIOSECURE Act (21)
Biosimilars (226)
Biotechnology (340)
Bladder cancer (191)
Brain cancer (75)
Breast cancer (746)
Cancer (5879)
Cardiovascular disease (502)
Career advice (2449)
Career pathing (47)
CAR-T (336)
CDC (67)
Celiac Disease (2)
Cell therapy (895)
Cervical cancer (45)
Clinical research (74947)
Collaboration (2150)
Company closure (5)
Compensation (1347)
Complete response letters (95)
COVID-19 (2962)
CRISPR (112)
C-suite (1124)
Cystic fibrosis (159)
Data (7604)
Decentralized trials (3)
Denatured (49)
Depression (178)
Dermatology (72)
Diabetes (592)
Diagnostics (7257)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (340)
Drug pricing (227)
Drug shortages (34)
Duchenne muscular dystrophy (291)
Earnings (94030)
Editorial (73)
Employer branding (23)
Employer resources (163)
Events (127458)
Executive appointments (1129)
FDA (21169)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1758)
Gene editing (239)
Generative AI (63)
Gene therapy (749)
GLP-1 (1170)
Government (5236)
Grass and pollen (8)
Guidances (405)
Healthcare (20343)
HIV (83)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (326)
Immuno-oncology (96)
Indications (168)
Infectious disease (3319)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (287)
Interviews (560)
IPO (17263)
IRA (59)
Job creations (4094)
Job search strategy (1984)
JPM (70)
Kidney cancer (20)
Labor market (97)
Layoffs (638)
Leadership (47)
Legal (8783)
Liver cancer (106)
Longevity (32)
Lung cancer (787)
Lymphoma (425)
Machine learning (57)
Management (63)
Manufacturing (1026)
MASH (196)
Medical device (14582)
Medtech (14670)
Mergers & acquisitions (21376)
Metabolic disorders (1580)
mRNA (224)
Multiple sclerosis (189)
NASH (24)
Neurodegenerative disease (434)
Neuropsychiatric disorders (119)
Neuroscience (3445)
Neurotech (1)
NextGen: Class of 2026 (7259)
Non-profit (4946)
Now hiring (75)
Obesity (762)
Opinion (345)
Ovarian cancer (212)
Pain (260)
Pancreatic cancer (290)
Parkinson's disease (374)
Partnered (34)
Patents (588)
Patient recruitment (654)
Peanut (66)
People (64569)
Pharmaceutical (82)
Pharmacy benefit managers (34)
Phase 1 (23377)
Phase 2 (32891)
Phase 3 (24483)
Pipeline (7831)
Policy (360)
Postmarket research (2935)
Preclinical (10069)
Press Release (70)
Prostate cancer (298)
Psychedelics (63)
Radiopharmaceuticals (339)
Rare diseases (1125)
Real estate (6482)
Recruiting (77)
Regulatory (27233)
Reports (56)
Research institute (2679)
Resumes & cover letters (457)
Rett syndrome (35)
RNA editing (25)
RSV (94)
Schizophrenia (184)
Series A (294)
Series B (219)
Service/supplier (13)
Sickle cell disease (117)
Special edition (29)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (3970)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (98)
The Weekly (106)
Vaccines (1196)
Venture capital (113)
Weight loss (514)
Women's health (121)
Worklife (23)
Date
Today (165)
Last 7 days (802)
Last 30 days (2868)
Last 365 days (31976)
2026 (10238)
2025 (31807)
2024 (37075)
2023 (41872)
2022 (53195)
2021 (57848)
2020 (56584)
2019 (49820)
2018 (37672)
2017 (34679)
2016 (34495)
2015 (40593)
2014 (34629)
2013 (29927)
2012 (31959)
2011 (32437)
2010 (30693)
Location
Africa (937)
Alabama (99)
Alaska (7)
Arizona (358)
Arkansas (16)
Asia (44571)
Australia (8061)
California (12987)
Canada (3699)
China (1365)
Colorado (556)
Connecticut (569)
Delaware (389)
Europe (100177)
Florida (1919)
Georgia (417)
Hawaii (3)
Idaho (66)
Illinois (1063)
India (90)
Indiana (592)
Iowa (25)
Japan (525)
Kansas (135)
Kentucky (51)
Louisiana (42)
Maine (75)
Maryland (1573)
Massachusetts (9385)
Michigan (365)
Minnesota (722)
Mississippi (7)
Missouri (157)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (91)
New Jersey (3446)
New Mexico (32)
New York (3434)
North Carolina (1743)
North Dakota (9)
Northern California (6424)
Ohio (387)
Oklahoma (24)
Oregon (45)
Pennsylvania (2606)
Puerto Rico (29)
Rhode Island (53)
South America (1308)
South Carolina (85)
South Dakota (2)
Southern California (5093)
Tennessee (207)
Texas (2061)
United States (46280)
Utah (390)
Vermont (1)
Virginia (315)
Washington D.C. (86)
Washington State (1067)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
786,549 Results for "ebb therapeutics formerly known as cereve inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerevance to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
·
1 min read
Press Releases
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
April 9, 2026
·
4 min read
Press Releases
Cerevance to Participate in the TD Cowen 46th Annual Health Care Conference
February 23, 2026
·
1 min read
Press Releases
Cerevance to Present Phase 2 Trial Results on OFF Time and Sleep‑Related Outcomes with Solengepras in Parkinson’s Disease at AD/PD™ 2026
March 10, 2026
·
4 min read
Press Releases
enGene Announces Name Change to enGene Therapeutics Inc.
April 7, 2026
·
8 min read
Press Releases
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
November 18, 2025
·
2 min read
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Press Releases
Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference
December 2, 2025
·
1 min read
Press Releases
Cerevance Announces Presentations at the Alzheimer’s Association International Conference 2025
July 14, 2025
·
3 min read
Press Releases
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
March 19, 2026
·
4 min read
1 of 78,655
Next
